Influence of exogenous, physiological and factors of chronic inflammatory process on indicators of disturbances of adaptive processes of the person
DOI:
https://doi.org/10.17721/fujcV8I2P183-202Keywords:
platelet aggregation, Willebrand factor, thrombosis, fibrin, hemostasis system, inflammation, exogenous, chemical and physiological factorsAbstract
Changes in laboratory parameters can be caused by physical, chemical, biological and other external factors, depending on physiological conditions, in most cases they have an adaptive nature, and it is not always possible to distinguish them from physiological fluctuations. At the same time, obvious shifts in laboratory parameters may indicate a violation of adaptation processes and damage of tissues and organs, despite the absence of clinical manifestations of a disease.
References
Savchenko RP, Gordyushina IV. Effect of oxidative stress on platelet activation in patients with renal pathology; 2004:48-51.
Orosz CG. Endothelial activation and chronic allograft rejection, Clin. Transplant;2014, pp.299-303.Orosz C.G. Endothelial activation and chronic allograft rejection, Clin. Transplant 2014:299-303.
Poller L, Thomson J. The partial thromboplastin (cephalin) time test. Journal of Clinical Pathology 1972;25(12):1038-1044. https://doi.org/10.1136/jcp.25.12.1038
Hattersley P, Hayse D. The Effect of Increased Contact Activation Time on the Activated Partial Thromboplastin Time. American Journal of Clinical Pathology 1976;66(3):479-482. https://doi.org/10.1093/ajcp/66.3.479
NEUBAUER R. Free radicals and antioxidants. The Lancet 1994;344(8934):1440-1442. https://doi.org/10.1016/s0140-6736(94)90612-2
Kattula S, Byrnes J, Wolberg A. Fibrinogen and Fibrin in Hemostasis and Thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2017;37(3):. https://doi.org/10.1161/atvbaha.117.308564
Mavrov GI, Belozerov AP 2003; Rudyk YuS, 2005, pp.16-18.
Smith S, Morrissey J. Polyphosphate enhances fibrin clot structure. Blood 2008;112(7):2810-2816. https://doi.org/10.1182/blood-2008-03-145755
Schmidt K, Noureen A, Kronenberg F, Utermann G. Structure, function, and genetics of lipoprotein (a). Journal of Lipid Research 2016;57(8):1339-1359. https://doi.org/10.1194/jlr.r067314
Ambunin VG, Zakharin AK. Conjugation of changes in catecholamines, thiol compounds and lipid peroxidation in bronchial asthma. 2011, pp.63-66.
Kisiel W, Canfield W, Ericsson L, Davie E. Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry 1977;16(26):5824-5831. https://doi.org/10.1021/bi00645a029
Nawroth P, Handley D, Esmon C, Stern D. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity.. Proceedings of the National Academy of Sciences 1986;83(10):3460-3464. https://doi.org/10.1073/pnas.83.10.3460
Moore K, Tabas I. Macrophages in the Pathogenesis of Atherosclerosis. Cell 2011;145(3):341-355. https://doi.org/10.1016/j.cell.2011.04.005
Dandekar A, Mendez R, Zhang K. Cross Talk Between ER Stress, Oxidative Stress, and Inflammation in Health and Disease. Methods in Molecular Biology 2015;:205-214. https://doi.org/10.1007/978-1-4939-2522-3_15
Abu Ebeyn Ahmad Mohamed. Clinico-immunological and pharmacological aspects in the local treatment of chronic prostatitis. Urology; 2003, pp.66-68.
Adaskevich VP. Sexually transmitted diseases. – Vitebsk: edit. Vitebsk medical university; 2014, p.310
Guskov AR, Yacevich GB, Turna AA. Laboratory monitoring of aspirate in transurethral drainage of the prostate gland in patients with chronic obstructive prostatitis, Urology; 2011, pp.15-20.
Visir V, Makurina G. State of free-radical processes and antioxidant defence of patients with psoriasis and concomitant essential hypertension. Zaporozhye Medical Journal 2016;0(4):. https://doi.org/10.14739/2310-1210.2016.4.79730
Brott D, Katein A, Thomas H, Lawton M, Montgomery R, Richardson R, Louden C. Evaluation of von Willebrand Factor and von Willebrand Factor Propeptide in Models of Vascular Endothelial Cell Activation, Perturbation, and/or Injury. Toxicologic Pathology 2014;42(4):672-683. https://doi.org/10.1177/0192623313518664
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).